DK1071425T3 - Behandling af depression og farmaceutiske præparater dertil - Google Patents

Behandling af depression og farmaceutiske præparater dertil

Info

Publication number
DK1071425T3
DK1071425T3 DK99918172T DK99918172T DK1071425T3 DK 1071425 T3 DK1071425 T3 DK 1071425T3 DK 99918172 T DK99918172 T DK 99918172T DK 99918172 T DK99918172 T DK 99918172T DK 1071425 T3 DK1071425 T3 DK 1071425T3
Authority
DK
Denmark
Prior art keywords
depression
treatment
pharmaceuticals
daily dose
folic acid
Prior art date
Application number
DK99918172T
Other languages
English (en)
Inventor
Alec James Coppen
Original Assignee
Scarista Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9808840A external-priority patent/GB2336534A/en
Priority claimed from GBGB9815372.9A external-priority patent/GB9815372D0/en
Application filed by Scarista Ltd filed Critical Scarista Ltd
Application granted granted Critical
Publication of DK1071425T3 publication Critical patent/DK1071425T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99918172T 1998-04-24 1999-04-23 Behandling af depression og farmaceutiske præparater dertil DK1071425T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9808840A GB2336534A (en) 1998-04-24 1998-04-24 Anti-depressant - Folic Acid Combination
GBGB9815372.9A GB9815372D0 (en) 1998-07-15 1998-07-15 Treatment of depression and pharmaceutical preparations therefor
PCT/GB1999/001268 WO1999055338A1 (en) 1998-04-24 1999-04-23 Treatment of depression and pharmaceutical preparations therefor

Publications (1)

Publication Number Publication Date
DK1071425T3 true DK1071425T3 (da) 2007-12-27

Family

ID=26313533

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99918172T DK1071425T3 (da) 1998-04-24 1999-04-23 Behandling af depression og farmaceutiske præparater dertil

Country Status (14)

Country Link
EP (1) EP1071425B1 (da)
JP (1) JP2002512965A (da)
KR (1) KR100398791B1 (da)
AT (1) ATE369135T1 (da)
AU (1) AU765173B2 (da)
CA (1) CA2329665C (da)
DE (1) DE69936773T2 (da)
DK (1) DK1071425T3 (da)
ES (1) ES2292238T3 (da)
NO (1) NO20005341L (da)
NZ (1) NZ508310A (da)
PT (1) PT1071425E (da)
RU (1) RU2222329C2 (da)
WO (1) WO1999055338A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN04226A (da) * 2011-11-14 2015-05-22 Gen Hospital Corp
RU2717343C1 (ru) * 2019-03-01 2020-03-23 Евгений Владимирович Плотников Средство, обладающее цитопротекторным действием
CN113350375A (zh) * 2021-05-24 2021-09-07 北京斯利安药业有限公司 一种药用组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2072504B (en) * 1980-03-27 1983-10-26 Coppen A J Pharmaceutical compositions
EP0089948B1 (en) * 1981-10-05 1985-08-14 COPPEN, Alec James Pharmaceutical compositions
EP0386117B1 (en) * 1987-10-22 1999-01-07 Massachusetts Institute Of Technology Treating premenstrual or late luteal phase syndrome
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки

Also Published As

Publication number Publication date
ES2292238T3 (es) 2008-03-01
ATE369135T1 (de) 2007-08-15
NZ508310A (en) 2005-03-24
NO20005341D0 (no) 2000-10-23
PT1071425E (pt) 2007-11-16
AU765173B2 (en) 2003-09-11
WO1999055338A1 (en) 1999-11-04
EP1071425A1 (en) 2001-01-31
EP1071425B1 (en) 2007-08-08
CA2329665A1 (en) 1999-11-04
KR20010072579A (ko) 2001-07-31
RU2222329C2 (ru) 2004-01-27
KR100398791B1 (ko) 2003-09-19
DE69936773D1 (de) 2007-09-20
DE69936773T2 (de) 2008-04-30
AU3620399A (en) 1999-11-16
CA2329665C (en) 2007-09-04
NO20005341L (no) 2000-12-08
JP2002512965A (ja) 2002-05-08

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
NO20062398L (no) Daglig, oral, kontrollert frigivnings oksycodon-doserings form
MXPA03011538A (es) Composicion medicinal que sustancialmente no causaria dano a la mucosa intestinal.
DK0959888T3 (da) Anvendelse af det chelerende middel clioquinol til fremstillingen af et farmaceutisk præparat til behandlingen af Alzheimer's sygdom
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
BG106251A (en) Levodopa (carbidopa) entacapone pharmaceutical preparation
DE60020551D1 (de) Orale formulierung zur verabreichung in den ileum enthaltend einen hemmstoff des ileum-gallensäuretransports
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
IS6970A (is) Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP
RS54050B1 (en) FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
HK1068606A1 (en) Novel aminobenzoephenones
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
MXPA04003520A (es) Formulacion farmaceutica que comprende (r)-bicalutamida.
DK1071425T3 (da) Behandling af depression og farmaceutiske præparater dertil
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
MXPA04001805A (es) Nueva forma de dosificacion oral de liberacion prolongada.
AU1243101A (en) High dose folic acid for the treatment of hyperhomocysteinemia
NZ515173A (en) Treatment of hypersensitivity reaction disorders
MD2068G2 (ro) Metodă de tratament al infecţiei cu Herpes simplex
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose